Suppressing cell growth and inducing apoptosis by inhibiting miR‑23a‑5p in human bladder cancer

Li,Yifan; Quan,Jing; Pan,Xiang; Zhou,Jingcheng; He,Anbang; Lai,Yongqing; Zhou,Guangchen

doi:10.3892/mmr.2018.9527

Suppressing cell growth and inducing apoptosis by inhibiting miR‑23a‑5p in human bladder cancer

Authors:
- Yifan Li
- Jing Quan
- Xiang Pan
- Jingcheng Zhou
- Anbang He
- Yongqing Lai
- Guangchen Zhou
View Affiliations

Affiliations: Department of Urology, Clinical Medical College of Yangzhou University, Subei People's Hospital of Jiangsu, Yangzhou, Jiangsu 225001, P.R. China, Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China, Department of Urology, Shenzhen Second People's Hospital, Shenzhen, Guangdong 518039, P.R. China
Published online on: October 2, 2018 https://doi.org/10.3892/mmr.2018.9527
Pages: 5256-5260

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) are a class of non‑coding RNAs, which are important in the initiation and progression of cancer. miRNA‑23a‑5p (miR‑23a‑5p) is a novel miRNA, which promotes cell growth and survival in several types of cancer. The aim of the present study was to investigate the expression and functional significance of miR‑23a‑5p in bladder cancer. Microchip assays have shown that miR‑23a‑5p is significantly upregulated in human bladder cancer. In the present study, it was found that miR‑23a‑5p was upregulated in bladder cancer tissues, compared with paired normal urothelial tissues by reverse transcription‑quantitative polymerase chain reaction. The impact of miR‑23a‑5p on cell proliferation, cell migration and apoptosis was determined by a 3‑(4,5‑dimethylthi‑azol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay, wound scratch assay and flow cytometry. The inhibition of cell proliferation and induction of apoptosis were also observed in miR‑23a‑5p inhibitor‑transfected T24 and SW780 human bladder cancer cells. These data suggested that miR‑23a‑5p has an oncogenic role and may be a therapeutic target for bladder cancer.

View Figures

View References

1	Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström PU, Choi W and Kassouf W: Bladder cancer. Lancet. 23:30512–30518. 2016.
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
3	IARC: Cancer incidence and mortality worldwide. http://globocan.iarc.fr2016.
4	Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A and Bray F: Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 71:96–108. 2017. View Article : Google Scholar : PubMed/NCBI
5	Babjuk M: Trends in bladder cancer incidence and mortality: Success or disappointment? Eur Urol. 71:106–110. 2016.
6	Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
7	Chhabra R, Dubey R and Saini N: Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer. 9:2322010. View Article : Google Scholar : PubMed/NCBI
8	Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
9	Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Chen J, et al: MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 6:e182862011. View Article : Google Scholar : PubMed/NCBI
10	Li Y, Chen D, Jin L, Liu J, Su Z, Li Y, Gui Y and Lai Y: MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Mol Med Rep. 13:1895–1901. 2016. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Rupaimoole R, Calin GA, Lopez-Berestein G and Sood AK: miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
13	Pickering MT, Stadler BM and Kowalik TF: miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene. 28:140–145. 2009. View Article : Google Scholar : PubMed/NCBI
14	Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
15	Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
16	Chan YC, Khanna S, Roy S and Sen CK: miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 286:2047–2056. 2011. View Article : Google Scholar : PubMed/NCBI
17	Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J, Yuan J, Qiang B and Peng X: cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc Natl Acad Sci USA. 109:15805–15810. 2012. View Article : Google Scholar : PubMed/NCBI
18	Listing H, Mardin WA, Wohlfromm S, Mees ST and Haier J: MiR-23a/−24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Br J Cancer. 112:131–139. 2015. View Article : Google Scholar : PubMed/NCBI
19	Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M and Li X: MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. Febs J. 277:3726–3734. 2010. View Article : Google Scholar : PubMed/NCBI
20	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Handbook. 7th edition. Springer; New York, NY: pp. 479–489. 2009